Updated osteoporosis guidelines have arrived from the American Association of Clinical Endocrinology. The AACE guidelines include different recommendations from the 2017 National Osteoporosis Foundation guidelines, primarily due to new anabolic agents. Learn about a newly created a new patient risk stratified category, the role of bisphosphonates, and how to approach patient care.Additional Resources/References:FRAX calculator: US version https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9; AACE osteoporosis guidelineshttps://www.aace.com/disease-stateresources/reproductive-and-gonad/clinical-practiceguidelines-recent-news-and-updatesThis episode is accredited for CPE. Subscribe at CEimpact(https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

Follow CEimpact on Social Media:
LinkedIn
Instagram